title: Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis.
abstract: Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), is a disease with world wide consequences, affecting nearly a third of the world's population. The established vaccine for TB, an attenuated strain of Mycobacterium bovis Calmette Guerin (BCG), has existed since 1921. Lactoferrin, an iron-binding protein found in mucosal secretions and granules of neutrophils was hypothesized to be an ideal adjuvant to enhance the efficacy of the BCG vaccine, specifically because of previous reports of lactoferrin enhancement of IL-12 production from macrophages infected with BCG. Different vaccination protocols were investigated for generation of host protective responses against MTB infection using lactoferrin admixed to the BCG vaccine. Resulting effects demonstrate that BCG/lactoferrin increased host protection against MTB infection by decreasing organ bacterial load and reducing lung histopathology; significant reduction in tissue CFUs and pathology were observed post-challenge compared to those seen with BCG alone. Addition of lactoferrin to the vaccine led to reduced pathological damage upon subsequent infection with virulent MTB, with positive results demonstrated when admixed in oil-based vehicle (incomplete Freund's adjuvant, IFA) or when given with BCG in saline. The observed post-challenge results paralleled increasing production of IFN-gamma and IL-6, but only limited changes to proinflammatory mediators TNF-alpha or IL-1beta from BCG-stimulated splenocytes. Overall, these studies indicate that lactoferrin is a useful and effective adjuvant to improve efficacy of the BCG vaccine, with potential to reduce related tissue damage and pulmonary histopathology.
authors: Department of Pathology and Laboratory Medicine, University of Texas-Houston Medical School, Houston, TX 77030, United States.
authors: Shen-An
authors: SA
authors: Hwang
authors: Katarzyna M
authors: KM
authors: Wilk
authors: Monika
authors: M
authors: Budnicka
authors: Margaret
authors: M
authors: Olsen
authors: Yogesh A
authors: YA
authors: Bangale
authors: Robert L
authors: RL
authors: Hunter
authors: Marian L
authors: ML
authors: Kruzel
authors: Jeffrey K
authors: JK
authors: Actor
mesh_terms: D000818:Animals; D000941:Antigens / Q000276:immunology; D001500:BCG Vaccine / Q000276:immunology*; D004304:Dosage Forms; D005260:Female; D007117:Immunization, Secondary; D007371:Interferon-gamma / Q000235:genetics; D007781:Lactoferrin / Q000276:immunology*; D008168:Lung / Q000276:immunology / Q000382:microbiology; D051379:Mice; D008810:Mice, Inbred C57BL; D009169:Mycobacterium tuberculosis / Q000276:immunology* / Q000472:pathogenicity*; D009928:Organ Specificity / Q000276:immunology; D012333:RNA, Messenger / Q000235:genetics; D013154:Spleen / Q000276:immunology / Q000382:microbiology; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
chemical_list: D000941:Antigens; D001500:BCG Vaccine; D004304:Dosage Forms; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma; D007781:Lactoferrin
references: Pediatrics. 1995 Jul;96(1 Pt 1):29-35
references: 7596718
references: Immunol Today. 1995 Sep;16(9):417-9
references: 7546203
references: Biochem Cell Biol. 2002;80(1):1-6
references: 11908632
references: Int Immunopharmacol. 2002 Mar;2(4):475-86
references: 11962727
references: Exp Dermatol. 2002 Apr;11(2):126-34
references: 11994139
references: Arch Immunol Ther Exp (Warsz). 2002;50(6):399-410
references: 12546066
references: Infect Immun. 2003 Apr;71(4):1656-61
references: 12654778
references: Nat Med. 2003 May;9(5):533-9
references: 12692540
references: Genome Res. 1996 Oct;6(10):986-94
references: 8908518
references: Genome Res. 1996 Oct;6(10):995-1001
references: 8908519
references: J Immunol. 1997 Jan 1;158(1):330-7
references: 8977207
references: J Exp Med. 1997 Jul 7;186(1):39-45
references: 9206995
references: Biochem Mol Biol Int. 1997 Sep;43(1):79-87
references: 9315285
references: Eur J Immunol. 1997 Dec;27(12):3182-90
references: 9464804
references: Int J Tuberc Lung Dis. 1998 Mar;2(3):200-7
references: 9526191
references: J Dairy Res. 1998 May;65(2):283-93
references: 9627847
references: J Immunol. 1999 Mar 15;162(6):3504-11
references: 10092807
references: Int Immunopharmacol. 2005 Mar;5(3):591-9
references: 15683854
references: Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):107-14
references: 15687034
references: Vaccine. 2005 Mar 18;23(17-18):2109-14
references: 15755580
references: Clin Chest Med. 2005 Jun;26(2):167-82, v
references: 15837103
references: ILAR J. 2005;46(3):280-93
references: 15953835
references: Microbes Infect. 2005 May;7(5-6):962-7
references: 15890555
references: J Exp Med. 2005 Jun 20;201(12):1915-24
references: 15955839
references: Curr Opin Immunol. 2005 Aug;17(4):374-80
references: 15963709
references: J Virol. 2005 Oct;79(20):12871-9
references: 16188989
references: Vaccine. 2005 Dec 1;23(48-49):5526-32
references: 16105710
references: Trends Immunol. 2005 Dec;26(12):660-7
references: 16246622
references: J Interferon Cytokine Res. 1999 Oct;19(10):1183-93
references: 10547159
references: Tuber Lung Dis. 1999;79(4):243-50
references: 10692993
references: Clin Infect Dis. 2000 Jun;30 Suppl 3:S266-70
references: 10875797
references: Immunol Cell Biol. 2000 Aug;78(4):334-41
references: 10947857
references: Scand J Immunol. 2000 Oct;52(4):369-79
references: 11013008
references: J Mol Endocrinol. 2000 Oct;25(2):169-93
references: 11013345
references: Clin Infect Dis. 2000 Sep;31 Suppl 3:S64-7
references: 11010824
references: Immunol Lett. 2000 Nov 1;74(3):183-8
references: 11064098
references: Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13853-8
references: 11095745
references: Trends Cell Biol. 2000 Dec;10(12):542-50
references: 11121747
references: Annu Rev Immunol. 2001;19:93-129
references: 11244032
references: Scand J Immunol. 2001 May;53(5):464-74
references: 11309154
references: Tuberculosis (Edinb). 2001;81(1-2):141-6
references: 11463235
references: J Immunol. 2001 Dec 15;167(12):6957-66
references: 11739515
references: J Immunol. 2002 Feb 1;168(3):1322-7
references: 11801672
references: J Leukoc Biol. 2002 Feb;71(2):271-8
references: 11818448
references: Lancet Infect Dis. 2002 Feb;2(2):86-92
references: 11901655
references: Infect Immun. 2006 Jan;74(1):557-65
references: 16369012
references: Clin Vaccine Immunol. 2006 Feb;13(2):239-45
references: 16467332
references: Infect Immun. 2006 Apr;74(4):2128-37
references: 16552042
references: Med Microbiol Immunol. 2007 Sep;196(3):171-80
references: 17377816
references: Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10188-92
references: 7901851
references: Int J Parasitol. 2003 May;33(5-6):547-54
references: 12782054
references: Scand J Immunol. 2003 Oct;58(4):449-61
references: 14507310
references: J Immunol. 2003 Nov 1;171(9):4750-7
references: 14568951
references: Curr HIV Res. 2003 Jul;1(3):309-20
references: 15046255
references: Biosci Biotechnol Biochem. 2004 Mar;68(3):537-44
references: 15056884
references: Vaccine. 2004 Mar 29;22(11-12):1498-508
references: 15063575
references: Vaccine. 2004 Feb 25;22(8):1063-71
references: 15161084
references: J Interferon Cytokine Res. 2004 Jun;24(6):362-71
references: 15212710
references: Biometals. 2004 Jun;17(3):231-4
references: 15222470
references: J Exp Med. 1970 Mar 1;131(3):559-70
references: 5413328
references: Cell. 1989 Mar 10;56(5):731-40
references: 2647299
references: Arch Dis Child. 1992 May;67(5):657-61
references: 1599309
references: Eur J Clin Nutr. 1993 Apr;47(4):232-41
references: 8491159
references: J Exp Med. 1993 Dec 1;178(6):2243-7
references: 8245795
references: Eur J Immunol. 1994 Apr;24(4):793-8
references: 7908633
references: Immunology. 1995 Mar;84(3):423-32
references: 7751026